Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist episode artwork

EPISODE · Nov 28, 2023 · 28 MIN

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist

from Keeping Current CME

Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)? Credit available for this activity expires: 11/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998529?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Nov 28, 2023

Embed this episode

Ready to play

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist

0:00 28:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 28 minutes long.

When was this Keeping Current CME episode published?

This episode was published on November 28, 2023.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!